European expansion Singota has recently expanded facilities and offices in Switzerland and Europe, signaling an international growth trajectory and potential for cross-border CDMO collaborations, strategic partnerships, and regional servicing opportunities for European and Swiss-based clients.

CDMO capabilities As a cGMP compliant FDA-registered CDMO offering formulation development, aseptic manufacturing, analytical testing, labeling and kitting, and supply chain management, Singota can address end-to-end outsourcing needs for mid-market pharmaceutical firms seeking reliable, quality-driven external development and manufacturing.

RKI framework The Risk Knowledge Infinity framework demonstrates a formal approach to risk assessment in formulation and process development, a selling point for risk-averse clients seeking robust quality systems and proactive process optimization to reduce development timelines.

Leadership voice Founders and executives actively participate in industry panels and events, presenting on topics like onshoring and talent development, which can be leveraged for co-marketing, speaking engagements, and identifying potential enterprise customers prioritizing domestic supply resilience.

Growth momentum Continued European facility openings and a multi-year expansion cadence indicate sustained capacity growth and capability enhancements, creating opportunities to win new multi-site contracts with global or regional biopharma and pharma clients seeking scalable CDMO partnerships.